ResultsIQ

ResultsIQ › Latest results › Tata Chemicals Limited

Tata Chemicals Limited Q4 FY25 results press release summary

NSE: TATACHEM · BSE: 500770

Results press release of 7 May 2025, summarised by AI from the filing.

Tata Chemicals Q4FY25 consolidated revenue ₹3,509 cr, up 1%, EBITDA ₹327 cr; board recommends dividend of ₹11 per share.

Key takeaways

  1. Q4 revenue Consolidated revenue from operations ₹3,509 cr, up by 1% compared to Q4FY24, with pricing pressure continuing in all geographies.
  2. Q4 EBITDA Consolidated EBITDA ₹327 cr compared to ₹443 cr in Q4FY24, mainly on account of lower pricing.
  3. Q4 PAT Consolidated PAT (before exceptional items and NCI) from continuing operations ₹(12) cr compared to ₹145 cr for Q4FY24.
  4. Lostock closure Soda Ash unit in Lostock, UK ceased operations from early February 2025, resulting in an additional exceptional charge of ₹55 cr.
  5. Gross debt As on March 31, 2025, stood at ₹7,072 cr (including lease of ₹768 cr), up by ₹1,509 cr on account of higher working capital loan in India, US & UK.

Original filing on BSE

Tata Chemicals Limited Q1 FY27 results

As filed: Revenue ₹4,255 cr (+14% year on year), EBITDA ₹555 cr (−14% year on year), PAT ₹60.0 cr (−81% year on year), EBITDA margin 13.0% (−441 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹3,438 cr (−2% year on year), EBITDA ₹274 cr (−16% year on year), PAT −₹2,116 cr, EBITDA margin 8.0% (−135 bps). Score 15 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA growth was below it. EBITDA margin fell 135 bps year on year. Revenue fell 3% from last quarter. Share price after the results: −10.7% in 30 days (Nifty 500: −1.7%).
  • Q3 FY26: Revenue ₹3,550 cr (−1% year on year), EBITDA ₹345 cr (−21% year on year), PAT −₹69.0 cr (−265% year on year), EBITDA margin 9.7% (−237 bps). Score 20 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA growth was below it; profit before exceptional items growth was well below it. EBITDA margin fell 237 bps year on year. Revenue fell 8% from last quarter. Share price after the results: −2.6% in 30 days (Nifty 500: −1.9%).
  • Q2 FY26: Revenue ₹3,877 cr (−3% year on year), EBITDA ₹537 cr (−13% year on year), PAT ₹154 cr (−19% year on year), EBITDA margin 13.9% (−160 bps). Score 27 of 100, Below trend. Revenue, EBITDA and profit before exceptional items growth were below the company's own trend. EBITDA margin fell 160 bps year on year. Other income 76% of PBT. Tax rate 45%. Consolidated profit -42% but standalone +80%. Profit fell 23% from last quarter. Share price after the results: −10.7% in 30 days (Nifty 500: +0.9%).
  • Q1 FY26: Revenue ₹3,719 cr (−2% year on year), EBITDA ₹649 cr (+13% year on year), PAT ₹316 cr (+66% year on year), EBITDA margin 17.5% (+230 bps). Score 54 of 100, In line with trend. Revenue growth was in line with the company's own trend; EBITDA and profit growth were above it. EBITDA margin rose 230 bps year on year. Other income 30% of PBT. Tax rate 14%. Share price after the results: −0.4% in 28 days (Nifty 500: −0.1%).
  • Q4 FY25: Revenue ₹3,509 cr (+1% year on year), EBITDA ₹327 cr (−26% year on year), PAT −₹49.0 cr (−139% year on year), EBITDA margin 9.3% (−343 bps). Score 20 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA and profit before exceptional items growth were well below it. EBITDA margin fell 343 bps year on year. Profit fell 279% from last quarter. Share price after the results: +13.1% in 30 days (Nifty 500: +5.0%).
  • Q3 FY25: Revenue ₹3,590 cr (−4% year on year), EBITDA ₹434 cr (−20% year on year), PAT −₹21.0 cr (−83% year on year), EBITDA margin 12.1% (−244 bps). Score 32 of 100, Below trend. Revenue growth was below the company's own trend; EBITDA and profit before exceptional items growth were well below it. EBITDA margin fell 244 bps year on year. Revenue fell 10% from last quarter.
  • Q2 FY25: Revenue ₹3,999 cr (0% year on year), EBITDA ₹618 cr (−25% year on year), PAT ₹267 cr (−46% year on year), EBITDA margin 15.5% (−503 bps). Score 5 of 100, Below trend. EBITDA margin fell 503 bps year on year. Other income 36% of PBT. Not enough history for a trend yet: scored on growth alone.

Past price moves after results do not indicate future moves. Not a recommendation.

Tata Chemicals Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.